"10.1371_journal.pmed.1000321","plos medicine","2010-08-10T00:00:00Z","Rajesh T Gandhi; Lu Zheng; Ronald J Bosch; Ellen S Chan; David M Margolis; Sarah Read; Beatrice Kallungal; Sarah Palmer; Kathy Medvik; Michael M Lederman; Nadia Alatrakchi; Jeffrey M Jacobson; Ann Wiegand; Mary Kearney; John M Coffin; John W Mellors; Joseph J Eron; on behalf of the AIDS Clinical Trials Group A5244 team","Massachusetts General Hospital and Ragon Institute, Boston, Massachusetts, United States of America; Harvard School of Public Health, Boston, Massachusetts, United States of America; University of North Carolina, Chapel Hill, North Carolina, United States of America; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America; Social & Scientific Systems, Silver Spring, Maryland, United States of America; Karolinska Institute, Stockholm, Sweden; Case Western Reserve University, Cleveland, Ohio, United States of America; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America; Drexel University, Philadelphia, Pennsylvania, United States of America; National Cancer Institute, Frederick, Maryland, United States of America; Tufts University, Boston, Massachusetts, United States of America; University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America","ICMJE criteria for authorship read and met: RTG LZ RJB ESC DMM SR BK SP KM MML NA JMJ AW MK JMC JWM JJE. Agree with the manuscripts results and conclusions: RTG LZ RJB ESC DMM SR BK SP KM MML NA JMJ AW MK JMC JWM JJE. Designed the experiments/the study: RTG LZ RJB DMM SR BK JMJ JMC JWM JJE. Analyzed the data: RTG LZ RJB ESC DMM SP KM MML NA JMJ MK JMC JWM. Collected data/did experiments for the study: RTG SP AW MK JWM JJE. Enrolled patients: RTG DMM JWM JJE. Wrote the first draft of the paper: RTG. Contributed to the writing of the paper: LZ RJB DMM BK SP MML NA JMJ MK JMC JWM JJE. Supervised immunology experiments for the study: NA. Performed Single Copy Analysis for the A5244 study and participated in monthly conference calls which discussed the study: AW. Directed the development of the assay used: JMC.","JWM: Gilead Sciences (consultant); Merck (consultant and grant support); Chimerix (consultant); RFS Pharmaceuticals (owns stock options). JJE: Merck, GlaxoSmithKline (consultant and grant support), Bristol-Myers Squibb, Tibotec, Chimerix, Avexa, and Tobira (consultant). RTG: Tibotec (research grant support) and Gilead (grant support). DM: Merck, Bristol-Myers Squibb, and GlaxoSmithKline (consultant and research support); Gilead Sciences (research support and common stock); Chimerix (consultant); Roche, Trimeris, and Tibotec (research support).","2010","08","Rajesh T Gandhi","RTG",18,TRUE,NA,1,13,1,TRUE,TRUE,TRUE,1,"18",TRUE
